血浆致动脉粥样硬化指数对高尿酸血症患者动脉粥样硬化性心血管疾病风险预测的增量价值
DOI:
作者:
作者单位:

(1.广西医科大学第一附属医院老年医学内分泌代谢科,广西南宁市530021;2.南宁市第一人民医院埌东医院内科,广西南宁市530022;3.广西老年疾病临床医学研究中心,广西南宁市530021;4.广西心脑血管疾病临床医学研究中心,广西南宁市530021)

作者简介:

黄丽清,硕士,副主任医师,研究方向为内分泌代谢疾病及慢性病管理,E-mail:115863759@qq.com。

通讯作者:

基金项目:

国家自然科学基金地区科学基金项目(82360179)


Incremental value of the atherogenic index of plasma for predicting atherosclerotic cardiovascular disease risk in patients with hyperuricemia
Author:
Affiliation:

1.Department of Geriatric Endocrinology and Metabolism, the First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi 530021, China;2.Department of Internal Medicine, Langdong Hospital, Nanning First People's Hospital, Nanning, Guangxi 530022, China;3.Guangxi Clinical Medical Research Center for Geriatric Diseases, Nanning, Guangxi 530021, China;4.Guangxi Clinical Research Center for Cardio-cerebrovascular Diseases, Nanning, Guangxi 530021, China)

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
    摘要:

    目的]探讨血浆致动脉粥样硬化指数(AIP)对高尿酸血症患者动脉粥样硬化性心血管疾病(ASCVD)事件风险预测的增量价值。 [方法]采用双中心回顾性研究设计,纳入2018年1月—2019年12月住院治疗的高尿酸血症患者,研究结局为随访期间首次发生的ASCVD事件。广西医科大学第一附属医院数据用于模型构建及内部验证,南宁市第一人民医院数据用于外部验证。采用最小绝对收缩和选择算子(LASSO)回归筛选基础预测因子,分别构建不含AIP和联合AIP的逻辑回归模型,并通过受试者工作特征曲线下面积(AUC)、综合判别改善指数(IDI)、净重分类改善指数(NRI)、Brier评分、决策曲线分析及沙普利加性解释(SHAP)等方法评估模型性能。 [结果]建模数据集纳入633例患者,其中发生ASCVD事件267例;外部验证集纳入132例患者,其中发生ASCVD事件40例。LASSO回归筛选出年龄、糖化血红蛋白(HbA1c)、高血压、肌酐、糖尿病、吸烟史、性别和收缩压8个基础预测因子。加入AIP后,内部测试集AUC由0.809提高至0.838,Brier评分由0.173降至0.158,同时IDI为0.041(P=0.008),NRI为0.158(P=0.005);外部验证集AUC由0.810提高至0.858,Brier评分由0.162降至0.140,同时IDI为0.061(P=0.018),NRI为0.283(P<0.001)。决策曲线和SHAP分析提示,AIP可改善模型临床净获益,且具有较高变量重要性。 [结论]AIP可在传统临床危险因素基础上提高高尿酸血症患者ASCVD事件风险预测效能,具有一定增量预测价值,可作为该人群风险分层的潜在补充指标。

    Abstract:

    Aim To investigate the incremental predictive value of the atherogenic index of plasma (AIP) for atherosclerotic cardiovascular disease (ASCVD) events in patients with hyperuricemia. Methods This dual-center retrospective study included patients with hyperuricemia who were hospitalized between January 2018 and December 2019.The primary outcome was the first occurrence of ASCVD events during follow-up. Data from the First Affiliated Hospital of Guangxi Medical University were used for model development and internal validation, whereas data from Nanning First People's Hospital were used for external validation. Least absolute shrinkage and selection operator (LASSO) regression was used to select baseline predictors. Logistic regression models with and without AIP were constructed. Model performance was evaluated using the area under the receiver operating characteristic curve (AUC), integrated discrimination improvement (IDI), net reclassification improvement (NRI), Brier score, decision curve analysis (DCA), and Shapley additive explanations (SHAP) analysis. Results The modeling dataset included 633 patients, of whom 267 experienced ASCVD events. The external validation dataset included 132 patients, of whom 40 experienced ASCVD events. LASSO regression selected eight baseline predictors:age, glycated hemoglobin A1c (HbA1c), hypertension, creatinine, diabetes, smoking history, sex, and systolic blood pressure. After the addition of AIP, the AUC in the internal test set increased from 0.809 to 0.838, and the Brier score decreased from 0.173 to 0.158, with an IDI of 0.041 (P=0.008) and an NRI of 0.158 (P=0.005). In the external validation set, the AUC increased from 0.810 to 0.858, and the Brier score decreased from 0.162 to 0.140, with an IDI of 0.061 (P=0.018) and an NRI of 0.283 (P<0.001). Decision curve analysis and SHAP analysis indicated that AIP improved the clinical net benefit of the model and demonstrated relatively high feature importance. Conclusions AIP improves the predictive performance for ASCVD events in patients with hyperuricemia beyond traditional clinical risk factors. It may serve as a potential supplementary marker for risk stratification in this population.

    参考文献
    相似文献
    引证文献
引用本文

黄丽清,杨曦.血浆致动脉粥样硬化指数对高尿酸血症患者动脉粥样硬化性心血管疾病风险预测的增量价值[J].中国动脉硬化杂志,2026,34(10):962~972.

复制
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:2026-05-19
  • 最后修改日期:2026-08-05
  • 录用日期:
  • 在线发布日期: 2026-11-19